Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.

Potokiri A, Omeiza NA, Ajayi AM, Adeleke PA, Alagbonsi AI, Iwalewa EO

Open source

DOI
10.1016/j.crphys.2024.100132
Published
2024
Container
Current research in physiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.crphys.2024.100132,
  title = {Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.},
  author = {Potokiri A and Omeiza NA and Ajayi AM and Adeleke PA and Alagbonsi AI and Iwalewa EO},
  year = {2024},
  journal = {Current research in physiology},
  doi = {10.1016/j.crphys.2024.100132},
  url = {https://doi.org/10.1016/j.crphys.2024.100132}
}

RIS

TY  - JOUR
TI  - Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.
AU  - Potokiri A
AU  - Omeiza NA
AU  - Ajayi AM
AU  - Adeleke PA
AU  - Alagbonsi AI
AU  - Iwalewa EO
PY  - 2024
JO  - Current research in physiology
DO  - 10.1016/j.crphys.2024.100132
UR  - https://doi.org/10.1016/j.crphys.2024.100132
ER  - 

APA

A, P., NA, O., AM, A., PA, A., AI, A., & EO, I. (2024). Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.. Current research in physiology. https://doi.org/10.1016/j.crphys.2024.100132

Source records